[PDF][PDF] Randomized controlled trial of a computerized decision aid on adjuvant radioactive iodine treatment for patients with early-stage papillary thyroid cancer
…, L Rotstein, JD Brierley, RW Tsang, S Asa, P Segal… - J Clin Oncol, 2012 - Citeseer
Purpose Decision-making on adjuvant radioactive iodine (RAI) treatment for early-stage
papillary thyroid cancer (PTC) is complex because of uncertainties in medical evidence. Using a …
papillary thyroid cancer (PTC) is complex because of uncertainties in medical evidence. Using a …
A phosphomimetic mutation at Ser-138 renders iron regulatory protein 1 sensitive to iron-dependent degradation
…, D Chahine, A Caltagirone, P Segal… - … and Cellular Biology, 2003 - Taylor & Francis
Iron regulatory protein 1 (IRP1) binds to mRNA iron-responsive elements (IREs) and thereby
controls the expression of IRE-containing mRNAs. In iron-replete cells, assembly of a …
controls the expression of IRE-containing mRNAs. In iron-replete cells, assembly of a …
[HTML][HTML] Best current practice and research priorities in active surveillance for prostate cancer—a report of a Movember international consensus meeting
…, NR Palmer, CC Paterson, MJ Roobol, P Segal… - European urology …, 2023 - Elsevier
Background Active surveillance (AS) is recommended for low-risk and some intermediate-risk
prostate cancer. Uptake and practice of AS vary significantly across different settings, as …
prostate cancer. Uptake and practice of AS vary significantly across different settings, as …
Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow‐up from a decision‐aid randomized trial
…, JD Brierley, RW Tsang, L Rotstein, S Ezzat, P Segal… - Cancer, 2015 - Wiley Online Library
BACKGROUND Patient decision aids (P‐DAs) inform medical decision making, but longer
term effects are unknown. This article describes extended follow‐up from a thyroid cancer …
term effects are unknown. This article describes extended follow‐up from a thyroid cancer …
A systematic review of randomized controlled trials for management of persistent post-treatment fatigue in thyroid cancer survivors
…, J Zhang, J Lowe, S Ezzat, J Gilbert, A Zahedi, P Segal… - Thyroid, 2015 - liebertpub.com
Background: Fatigue that persists post-treatment is commonly reported by thyroid cancer (TC)
survivors. Methods: A systematic review of published English language randomized …
survivors. Methods: A systematic review of published English language randomized …
[HTML][HTML] Challenges of telemonitoring programs for complex chronic conditions: randomized controlled trial with an embedded qualitative study
P Ware, A Shah, HJ Ross, AG Logan, P Segal… - Journal of Medical …, 2022 - jmir.org
Background Despite the growing prevalence of people with complex conditions and
evidence of the positive impact of telemonitoring for single conditions, little research exists on …
evidence of the positive impact of telemonitoring for single conditions, little research exists on …
[HTML][HTML] Self-management and clinical decision support for patients with complex chronic conditions through the use of smartphone-based telemonitoring: randomized …
…, JA Cafazzo, KR Chapman, P Segal… - JMIR Research …, 2017 - researchprotocols.org
Background: The rising prevalence of chronic illnesses hinders the sustainability of the health
care system because of the high cost of frequent hospitalizations of patients with complex …
care system because of the high cost of frequent hospitalizations of patients with complex …
Maternal obesity and familial history of diabetes have opposing effects on infant birth weight in women with mild glucose intolerance in pregnancy
P Segal, JK Hamilton, M Sermer… - The Journal of …, 2008 - Taylor & Francis
Objective. Pregnant women with an abnormal screening glucose challenge test (GCT) but
without gestational diabetes mellitus (GDM) on subsequent oral glucose tolerance test (OGTT) …
without gestational diabetes mellitus (GDM) on subsequent oral glucose tolerance test (OGTT) …
[HTML][HTML] Concerns of low-risk thyroid cancer survivors
…, RW Tsang, JD Brierley, L Rotstein, P Segal… - Acta …, 2016 - Taylor & Francis
Results Our survey response rate was 77%(57/74) and mean duration of time since the initial
surgical treatment was 35 months (range 29–45 months)[Citation 5, Citation 6]. Only two …
surgical treatment was 35 months (range 29–45 months)[Citation 5, Citation 6]. Only two …
Exploring the Needs of Adults Living With Type 1 or Type 2 Diabetes Distress Using the Problem Areas in Diabetes 5 Tool
C Mach, J Bulanadi, E Gucciardi, P Segal… - Canadian Journal of …, 2023 - Elsevier
Objectives This study investigated the feasibility and acceptability of implementing a screening
tool as a part of routine care and the subsequent screening experiences of patients and …
tool as a part of routine care and the subsequent screening experiences of patients and …
